NCT04799704

Brief Summary

To investigate the presence of SARS-nCoV-2 in the tear film of symptomatic and pauci-symptomatic SARS-nCoV-2 positive patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 16, 2021

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

January 24, 2025

Completed
Last Updated

January 24, 2025

Status Verified

June 1, 2022

Enrollment Period

3 months

First QC Date

March 11, 2021

Results QC Date

June 28, 2022

Last Update Submit

December 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Presence of SARS-nCoV-2 in the Tear Film of Symptomatic and Pauci-symptomatic SARS-nCoV-2 Positive Patients.

    Bilateral conjunctival sampling will be performed on both eyes after the application of a drop of topical anesthesia at least once.

    during hospitalization every 3 days until the day of discharge up to 1 month

Study Arms (1)

symptomatic patient

to confirm the detectability of the SARS-nCoV-2 in the tear film of symptomatic patients.

Diagnostic Test: swabbing of conjunctiva

Interventions

Each eye will be sampled with a single, sterile, nylon, flocked swab

symptomatic patient

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

positive test for SARS-nCoV-2 on a nasopharyngeal swab.

You may qualify if:

  • Subject needs to be above 18 years old.
  • The subject is willing to undergo sampling of the conjunctiva.
  • The subject is willing to fill in a questionnaire.
  • The subject is fluent in written and verbal Dutch.
  • The subject is capable of giving informed consent.
  • Applicable for part 1 only: the subject test positive for SARS-nCoV-2 on a nasopharyngeal swab. The time window between a positive nasopharyngeal swab and the first conjunctival swab may be no more than 3 days.

You may not qualify if:

  • Allergy to Oxybuprocainehydrochloride
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams Brabant, 3000, Belgium

Location

Related Publications (1)

  • Leysen L, Delbeke H, Desmet S, Schauwvlieghe PP, Maes P, Blanckaert G, Matthys E, Joossens M, Casteels I. In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients. Clin Microbiol Infect. 2022 Aug;28(8):1172-1173. doi: 10.1016/j.cmi.2022.03.026. Epub 2022 Mar 31. No abstract available.

Related Links

MeSH Terms

Conditions

COVID-19Eye Diseases

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Results Point of Contact

Title
Heleen Delbeke, MD
Organization
UZ Leuven

Study Officials

  • Delbeke Heleen, MD

    UZ Leuven

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 16, 2021

Study Start

September 11, 2020

Primary Completion

December 13, 2020

Study Completion

December 13, 2020

Last Updated

January 24, 2025

Results First Posted

January 24, 2025

Record last verified: 2022-06

Locations